Want to see PTKFY full AI Analyst Report?
PT Kalbe Farma Tbk (PTKFY) Ratios
PT Kalbe Farma Tbk Ratios
PTKFY's free cash flow for Q2 2026 was $847.74B. For the 2026 fiscal year, PTKFY's free cash flow was decreased by $-245.94B and operating cash flow was $1.09T. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.47 | 4.11 | 4.91 | 3.77 | 4.45 |
| Quick Ratio | 2.16 | 2.55 | 2.81 | 2.19 | 3.01 |
| Cash Ratio | 0.81 | 1.13 | 1.00 | 0.89 | 1.76 |
| Solvency Ratio | 0.75 | 0.74 | 0.79 | 0.80 | 0.88 |
| Operating Cash Flow Ratio | 0.61 | 1.14 | 0.90 | 0.85 | 0.80 |
| Short-Term Operating Cash Flow Coverage | 29.11 | 14.86 | 10.45 | 4.55 | 40.37 |
| Net Current Asset Value | $ 12.54T | $ 12.35T | $ 11.98T | $ 11.57T | $ 11.31T |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.02 | 0.02 | 0.04 | 0.02 |
| Debt-to-Equity Ratio | 0.01 | 0.02 | 0.03 | 0.06 | 0.03 |
| Debt-to-Capital Ratio | 0.01 | 0.02 | 0.03 | 0.05 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| Financial Leverage Ratio | 1.32 | 1.29 | 1.26 | 1.34 | 1.31 |
| Debt Service Coverage Ratio | 30.95 | 9.62 | 8.78 | 4.87 | 34.32 |
| Interest Coverage Ratio | 128.95 | 72.22 | 43.77 | 108.97 | 91.47 |
| Debt to Market Cap | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Interest Debt Per Share | 1467.61 | 2665.44 | 3033.13 | 5197.98 | 2865.79 |
| Net Debt to EBITDA | -0.72 | -0.90 | -0.65 | -0.53 | -1.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 39.79% | 39.71% | 38.83% | 40.45% | 42.97% |
| EBIT Margin | 13.63% | 13.10% | 12.12% | 15.60% | 16.00% |
| EBITDA Margin | 15.86% | 14.14% | 13.21% | 18.13% | 18.56% |
| Operating Profit Margin | 12.87% | 12.47% | 11.92% | 15.53% | 15.84% |
| Pretax Profit Margin | 13.53% | 12.93% | 11.92% | 15.41% | 15.78% |
| Net Profit Margin | 10.38% | 9.93% | 9.09% | 11.69% | 12.12% |
| Continuous Operations Profit Margin | 10.60% | 9.95% | 9.12% | 11.92% | 12.31% |
| Net Income Per EBT | 76.70% | 76.81% | 76.21% | 75.85% | 76.84% |
| EBT Per EBIT | 105.14% | 103.72% | 99.99% | 99.26% | 99.58% |
| Return on Assets (ROA) | 11.94% | 11.01% | 10.23% | 12.42% | 12.40% |
| Return on Equity (ROE) | 15.72% | 14.22% | 12.92% | 16.59% | 16.26% |
| Return on Capital Employed (ROCE) | 17.92% | 16.11% | 15.25% | 19.69% | 18.80% |
| Return on Invested Capital (ROIC) | 13.97% | 12.23% | 11.52% | 14.69% | 14.60% |
| Return on Tangible Assets | 12.91% | 11.97% | 10.94% | 13.15% | 12.99% |
| Earnings Yield | 7.17% | 4.20% | 2.67% | 3.65% | 4.32% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.99 | 6.51 | 6.55 | 6.04 | 7.41 |
| Payables Turnover | 8.85 | 10.40 | 11.02 | 8.63 | 8.98 |
| Inventory Turnover | 3.04 | 3.03 | 2.74 | 2.45 | 2.94 |
| Fixed Asset Turnover | 4.04 | 3.73 | 3.77 | 3.47 | 3.16 |
| Asset Turnover | 1.15 | 1.11 | 1.13 | 1.06 | 1.02 |
| Working Capital Turnover Ratio | 2.70 | 2.54 | 2.44 | 2.37 | 2.38 |
| Cash Conversion Cycle | 139.56 | 141.61 | 155.73 | 166.97 | 132.61 |
| Days of Sales Outstanding | 60.93 | 56.08 | 55.76 | 60.40 | 49.27 |
| Days of Inventory Outstanding | 119.87 | 120.64 | 133.10 | 148.87 | 123.98 |
| Days of Payables Outstanding | 41.23 | 35.11 | 33.13 | 42.30 | 40.64 |
| Operating Cycle | 180.80 | 176.72 | 188.86 | 209.27 | 173.25 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 14434.90 | 20720.95 | 12571.33 | 16207.13 | 12057.90 |
| Free Cash Flow Per Share | 10860.56 | 15306.71 | 7473.70 | 12466.05 | 7787.33 |
| Dividend Paid and CapEx Coverage Ratio | 1.34 | 1.78 | 0.99 | 1.51 | 1.22 |
| Capital Expenditure Coverage Ratio | 4.04 | 3.83 | 2.47 | 4.33 | 2.82 |
| Operating Cash Flow Coverage Ratio | 11.00 | 8.56 | 4.70 | 3.23 | 4.51 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.15 | 0.10 | 0.13 | 0.11 |
| Free Cash Flow Yield | 4.81% | 4.58% | 1.67% | 3.12% | 2.47% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 13.95 | 23.79 | 37.45 | 27.43 | 23.17 |
| Price-to-Sales (P/S) Ratio | 1.45 | 2.36 | 3.40 | 3.21 | 2.81 |
| Price-to-Book (P/B) Ratio | 2.19 | 3.38 | 4.84 | 4.55 | 3.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 20.78 | 21.81 | 59.94 | 32.00 | 40.42 |
| Price-to-Operating Cash Flow Ratio | 15.63 | 16.11 | 35.64 | 24.61 | 26.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.91 | 1.37 | -2.11 | 3.89 | 1.41 |
| Enterprise Value Multiple | 8.41 | 15.81 | 25.11 | 17.16 | 13.99 |
| Enterprise Value | 47.09T | 72.93T | 101.00T | 90.00T | 68.18T |
| EV to EBITDA | 8.41 | 15.81 | 25.11 | 17.16 | 13.99 |
| EV to Sales | 1.33 | 2.24 | 3.32 | 3.11 | 2.60 |
| EV to Free Cash Flow | 19.14 | 20.63 | 58.43 | 31.04 | 37.36 |
| EV to Operating Cash Flow | 14.40 | 15.24 | 34.74 | 23.88 | 24.13 |
| Tangible Book Value Per Share | 98917.10 | 96299.05 | 92278.43 | 88439.42 | 85798.18 |
| Shareholders’ Equity Per Share | 102888.53 | 98681.21 | 92610.79 | 87648.31 | 83542.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.23 | 0.23 | 0.23 | 0.22 |
| Revenue Per Share | 155903.36 | 141285.95 | 131655.87 | 124402.53 | 112052.67 |
| Net Income Per Share | 16175.31 | 14032.72 | 11962.86 | 14542.15 | 13584.05 |
| Tax Burden | 0.77 | 0.77 | 0.76 | 0.76 | 0.77 |
| Interest Burden | 0.99 | 0.99 | 0.98 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
| SG&A to Revenue | 0.15 | 0.15 | 0.02 | 0.02 | 0.02 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 14787.83 | 23434.01 | 1.05 | 1.11 | 0.89 |
Currency in IDR
